Skip to main content
Midas Edge

RxSight, Inc.

For the period ended Sep 30, 2026. Filed Nov 3, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 3, 2026

RXST$4.90+0.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Equity

CONDENSED CONSOLIDATED STATEMENTS OFSTOCKHOLDERS’ EQUITY

(In thousands, except number of shares)

Common stock · Additional paid-in capital · Accumulated other comprehensive loss · Accumulated deficit · Total stockholders' equity
Shares · Amount
Balance at December 31, 202541,242,005$41$936,628$53$(661,039)$275,683
Shares issued for the exercise of stock optionsand vesting of restricted stock units204,323—144——144
Shares redeemed for employee tax withholdings(62,208)—(473)——(473)
Stock-based compensation expense——7,945——7,945
Unrealized loss on short-term investments and cash equivalents, net of tax———(120)—(120)
Net loss————(15,884)(15,884)
Balance at March 31, 202641,384,120$41$944,244$(67)$(676,923)$267,295
Shares issued for the exercise of stock options and vesting of restricted stock units98,505—52——52
Stock-based compensation expense——7,465——7,465
Shares issued for the employee stock purchase plan102,756—617——617
Unrealized loss on short-term investments and cash equivalents, net of tax———(5)—(5)
Foreign currency translation adjustment———13—13
Net loss————(12,097)(12,097)
Balance at June 30, 202641,585,381$41$952,378$(59)$(689,020)$263,340
Shares issued for the exercise of stock options and vesting of restricted stock units345,6781225——226
Shares redeemed for employee tax withholdings(3,837)—(24)——(24)
Stock-based compensation expense——7,634——7,634
Unrealized loss on short-term investments and cash equivalents, net of tax———(59)—(59)
Foreign currency translation adjustment———18—18
Net loss————(16,224)(16,224)
Balance at September 30, 202641,927,222$42$960,213$(100)$(705,244)$254,911

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In thousands, except number of shares)

Common stock · Additional paid-in capital · Accumulated other · Accumulated deficit · Total stockholders' equity
Shares · Amount · comprehensive income (loss)
Balance at December 31, 202440,428,220$40$903,127$166$(622,095)$281,238
Shares issued for the exercise of stock options and vesting of restricted stock units210,3321696——697
Shares redeemed for employee tax withholdings(50,012)—(1,418)——(1,418)
Stock-based compensation expense——7,140——7,140
Unrealized loss on short-term investments and cash equivalents, net of tax———(157)—(157)
Foreign currency translation adjustment———6—6
Net loss————(8,190)(8,190)
Balance at March 31, 202540,588,540$41$909,545$15$(630,285)$279,316
Shares issued for the exercise of stock options and vesting of restricted stock units268,485—1,362——1,362
Stock-based compensation expense——8,547——8,547
Shares issued for the employee stock purchase plan56,355—705——705
Unrealized loss on short-term investments and cash equivalents, net of tax———(145)—(145)
Foreign currency translation adjustment———13—13
Net loss————(11,786)(11,786)
Balance at June 30, 202540,913,380$41$920,159$(117)$(642,071)$278,012
Shares issued for the exercise of stock options and vesting of restricted stock units241,943—131——131
Shares redeemed for employee tax withholdings(73,773)—(642)——(642)
Stock-based compensation expense-—8,108——8,108
Unrealized gain on short-term investments and cash equivalents, net of tax-——178—178
Foreign currency translation adjustment-——(1)—(1)
Net loss-———(9,816)(9,816)
Balance at September 30, 202541,081,550$41$927,756$60$(651,887)$275,970
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.